Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Chubb
Boehringer Ingelheim
McKesson
US Army
Fuji
Colorcon
Deloitte
Merck

Generated: November 18, 2018

DrugPatentWatch Database Preview

Estonia Supplementary Protection Certificates

« Back to Dashboard

Supplementary Protection Certificates

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
Country Document Number Supplementary Protection Certificate SPC Country SPC Description SPC Expiration
European Patent Office 1663240 C20150039 00166 Estonia PRODUCT NAME: RILPIVIRIINI (VESINIKKLORIIDSOOLANA) JA EMTRITSITABIINI;REG NO/DATE: EU/1/11/737/001-002 28.11.2011 ➤ Sign Up
European Patent Office 2288610 C20170022 00232 Estonia PRODUCT NAME: BARITSITINIIB;REG NO/DATE: EU/1/16/1170 15.02.2017 ➤ Sign Up
European Patent Office 1606261 C20100008 00033 Estonia PRODUCT NAME: DAXAS-ROFLUMILAST; REG NO/DATE: K(2010)4785 05.07.2010 ➤ Sign Up
European Patent Office 2203431 C20150015 00143 Estonia PRODUCT NAME: DASABUVIIR;REG NO/DATE: EU/1/14/983 19.01.2015 ➤ Sign Up
European Patent Office 2410844 C20160050 00207 Estonia PRODUCT NAME: ELBASVIIR;REG NO/DATE: EU/1/16/1119 26.07.2016 ➤ Sign Up
European Patent Office 1761528 C20140036 00120 Estonia PRODUCT NAME: TRAMETINIIB;REG NO/DATE: EU/1/14/931 02.07.2014 ➤ Sign Up
European Patent Office 2107069 C20130014 00133 Estonia PRODUCT NAME: DEGLUDEKINSULIIN/ASPARTINSULIIN;REG NO/DATE: K(2013)368 (LOPLIK) 23.01.2013 ➤ Sign Up
Country Document Number Supplementary Protection Certificate SPC Country SPC Description SPC Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Boehringer Ingelheim
Queensland Health
US Army
Merck
Cipla
Johnson and Johnson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.